Clinical trial NCT02170506: Effect of Sub-mental Sensitive Transcutaneous Electrical Stimulation on Pharyngeal Muscles Control : TENSVIRT Study
Official title: Effect of Sub-mental Sensitive Transcutaneous Electrical Stimulation on Pharyngeal Muscles Control
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Oropharyngeal Dysphagia
Deglutition Disorders
Lead sponsor: University Hospital, Rouen
Sponsor class: OTHER
First posted: 2014-06-23
Enrollment: 10
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP

Brief summary: Swallowing is a complex phenomenon that allows oral feeding while protecting the airway. It involves many brain areas, including primary motor and sensory areas. Its dysfunction, called oropharyngeal dysphagia is present in approximately 60% of patients with a stroke. In this case, it is conventionally translated by a swallow response time delay of the swallowing reflex.

Pathophysiology of dysphagia is explained by impairment of the dominant swallowing, function that representation center is bi-hemispheric but asymmetric (Hamdy, 1997). Half of patients with a stroke supra-tentoriel with oropharyngeal dysphagia (about 55 % of strokes) regain normal swallowing in a few weeks ( Barer, 1989). Mechanisms that determine the recovery appear to be related to a reorganization of the motor cortex intact. Patients who retain disorders are those who have not cortical reorganization.

With this in mind a team used different methods known to modulate brain plasticity, which electrotherapy with an application endo- pharyngeal sensory threshold. This stimulation increases the excitability of the cortico- bulbar reflex, which improves swallowing function in the clinical application.

The hypothesis of this work is that the transcutaneous electrical stimulation applied submental, noninvasive technique, would also have an impact on cortical plasticity may explain the improved coordination of swallowing observed in earlier studies (Verin , 2011) ( Gallas , 2010).


Eligibility criteria: Inclusion Criteria:

1. Subjects aged over 18 years
2. Affilitation to social security scheme
3. Registration in National register of people who participate in biomedical research
4. Healthy volunteers who provided written informed consent

Exclusion Criteria:

1. Subjects with swallowing disorders
2. Presence of psychiatric disorders
3. Skin disorders
4. Cardiac disorders (non controlled arrythmia, severe heart failure, presence of heart valve)
5. Submental tumor
6. Epilepsia, treated or untreated
7. Presence of neurosurgical clip
8. Suspicion of digestive fistula
9. Presence of metal, pacemaker, defibrillator, pump treatment or neurostimulation
10. Cannabis user, regular use of benzodiazepines
11. Presence of chronic respiratory, neurological disease, ENT or gastroesophageal disease (cause potentially change swallowing)
12. Contra-indication to MRI (claustrophobia, metal fragment, cardiac/ENT/neurological implantable device not MRI compatible, osteosynthesis prior to 1980)
13. Subject reported against the use of Micropaque®
14. Pregnant or nursing woman, or absence of contraception
15. Poor understanding of French langage
16. Person under judicial protection
17. Person deprive of their liberty by judicial or administrative decision
18. Participating in a clinical trial within 4 weeks before the pre-inclusion visit

Primary outcomes:
measure: Variation in motor evoked potential amplitude
timeFrame: 1 month
Secondary outcomes:
measure: variation of swallow reaction time
timeFrame: 1 Month
Other outcomes:
Locations:
city: Rouen
country: France
facility: UHRouen
Study officials:
affiliation: University Hospital, Rouen
name: Eric VERIN, Professor
role: PRINCIPAL_INVESTIGATOR
References: